4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-054073
Chief Scientific Officer sold 5,000 shares at $15.98 ($79,908)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2022-10-17 | Sale | −5,000 | $15.98 | $79,908 | 101,386 | D |
| Open-market sales · 5,000 sh · avg $15.98 · $79,908 | |||||||
Loading xslF345X03/doc4.xml…